Enliven Therapeutics Inc.

NASDAQ: ELVN · Real-Time Price · USD
20.24
0.47 (2.38%)
At close: Aug 15, 2025, 3:59 PM
20.22
-0.10%
After-hours: Aug 15, 2025, 04:20 PM EDT

Enliven Therapeutics Fail-to-Deliver

Total FTD Shares
12.35K
Below Average
FTD / Avg. Volume
2.47%
Low Impact
1-Year Change
> 100%
Positive Trend

FTD Chart

As of Jul 14, 2025, Enliven Therapeutics Inc. has 12,351 shares failed to deliver, representing 2.47% of the average daily volume of 500,311 shares. Over the past year, the monthly average FTD is 8,004 shares, with the current level 54% above the historical average, indicating elevated settlement pressure. The weighted FTD ratio above 1% suggests potential liquidity constraints or heightened short-selling activity.

FTD History

Date Price FTD Shares % Change
Jul 14, 2025 23 12.35K +2141.56%
Jun 27, 2025 20.68 551 -99.19%
May 30, 2025 17.77 67.96K +3119.19%
Apr 30, 2025 18.94 2.11K +146.90%
Mar 28, 2025 21.07 855 +1985.37%
Feb 28, 2025 20.83 41 -99.89%
Jan 31, 2025 21.86 38.68K +1837.11%
Dec 30, 2024 22.39 2K -47.24%
Nov 21, 2024 25.41 3.79K +551.46%
Oct 30, 2024 28.39 581 -67.49%
Sep 30, 2024 25.54 1.79K +6773.08%
Aug 19, 2024 23.53 26 -97.74%
Jul 30, 2024 26.13 1.15K -68.03%
Jun 28, 2024 23.37 3.59K +3386.41%
May 31, 2024 22.57 103 +1044.44%
Apr 30, 2024 17.39 9 -98.02%
Mar 25, 2024 17.78 455 +394.57%
Feb 29, 2024 15.97 92 -94.59%
Jan 30, 2024 16.28 1.7K +169800.00%
Dec 29, 2023 13.84 1 -99.57%
Nov 30, 2023 11.26 234 +27.17%
Oct 27, 2023 10.99 184 +1740.00%
Sep 25, 2023 13.89 10 -88.76%
Aug 11, 2023 17.54 89 -93.51%
Jul 28, 2023 18.7 1.37K +441.90%
Jun 30, 2023 20.41 253 -56.00%
May 31, 2023 18.3 575 +7087.50%
Apr 28, 2023 19.04 8 -99.71%
Mar 31, 2023 21.9 2.75K +623.68%
Feb 28, 2023 21.54 380 n/a